SCHEMBL29488460

SCHEMBL29488460

CC(C)N1CCC(NC(=O)/C(=C/CCCCC(=O)NO)COc2cccc3ccccc23)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 7/20 0.40
▸ HDAC6 Q9UBN7 7/20 0.40
▸ EHMT1 Q9H9B1 3/20 0.40
▸ HDAC3 O15379 4/20 0.39
▸ HDAC2 Q92769 3/20 0.39
▸ HDAC4 P56524 2/20 0.39
▸ HDAC7 Q8WUI4 2/20 0.39
▸ HDAC10 Q969S8 2/20 0.39
▸ HDAC11 Q96DB2 2/20 0.39
▸ HDAC8 Q9BY41 2/20 0.39
▸ HDAC9 Q9UKV0 2/20 0.39
▸ HDAC5 Q9UQL6 2/20 0.39
▸ P2RX3 P56373 1/20 0.39
▸ PREP P48147 1/20 0.38
▸ CASP1 P29466 2/20 0.38
▸ CASP3 P42574 2/20 0.38
▸ CASP7 P55210 2/20 0.38
▸ CASP8 Q14790 2/20 0.38
▸ EHMT2 Q96KQ7 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1306884 1.00 HDAC1 (0.40) HDAC1HDAC6EHMT1HDAC3HDAC2
SCHEMBL1306881 1.00 HDAC1 (0.40) HDAC1HDAC6EHMT1HDAC3HDAC2
SCHEMBL29488476 0.95 P2RX3 (0.39) HDAC1HDAC6EHMT1HDAC3HDAC2
SCHEMBL1306861 0.95 P2RX3 (0.39) HDAC1HDAC6EHMT1HDAC3HDAC2
SCHEMBL1306864 0.95 P2RX3 (0.39) HDAC1HDAC6EHMT1HDAC3HDAC2
SCHEMBL1306271 0.92 ALDH1A1 (0.43) P2RX3PREPCASP1CASP3CASP7
SCHEMBL1306268 0.92 ALDH1A1 (0.43) P2RX3PREPCASP1CASP3CASP7
SCHEMBL1306855 0.91 CNR2 (0.39) P2RX3PREPCASP1CASP3CASP7
SCHEMBL1306856 0.91 CNR2 (0.39) P2RX3PREPCASP1CASP3CASP7
SCHEMBL1306220 0.89 P2RX3 (0.42) HDAC1HDAC6HDAC3HDAC2HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114340672-A Pharmaceutical composition comprising an HDAC inhibitor and an anti-PD 1 antibody or an anti-PD-L1 antibody 晶体基因技术株式会社 2022-04-12 — — CN claimed
CN-112930177-B Pharmaceutical compositions containing alkylcarbamoyl naphthoyl octenoyl hydroxyamide phosphate, tartrate or combinations thereof and methods of making the same 晶体基因技术株式会社 2024-01-30 — — CN disclosed
CN-114340672-A Pharmaceutical composition comprising an HDAC inhibitor and an anti-PD 1 antibody or an anti-PD-L1 antibody 晶体基因技术株式会社 2022-04-12 — — CN disclosed
CN-110740989-B Pharmaceutically acceptable salts of alkylcarbamoylnaphthoxyoctenoylhydroxyamides or derivatives thereof and process for preparing the same 晶体基因技术株式会社 2022-03-08 — — CN disclosed
Send feedback